Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Leadership

From the AWS Loft, what hospital and pharma leaders, entrepreneurs, innovators, and more say will help speed up industry transformation.

Editor, Health & Life Sciences, Oliver Wyman

41% of founders and co-founders at this year’s StartUp Health festival were female. Here’s why this matters for (both female and male) healthcare leaders.

Editor, Health & Life Sciences, Oliver Wyman
Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman

Memorable highlights from the seventh annual Oliver Wyman Health Innovation Summit.

Hospital leaders share their biggest hopes and fears for an industry in transformation.

President and CEO, Dallas-Fort Worth Hospital Council
Chief Strategy Officer, Baylor Scott & White Health
CEO, Texas Health Resources
President and CEO, Henry Ford Health System

Diversity as a Strategic Priority

How can your I&D goals thrive? Walk the talk, says Florida Blue's CEO.

President and CEO, Florida Blue
CEO, Health Evolution
Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman

Insights in your inbox

Subscribe

Our most memorable moments, including Oliver Wyman's Inaugural Women in Healthcare Leadership Award.

Editor, Health & Life Sciences, Oliver Wyman

Our interviews and research unearth the visible and invisible forces contributing to healthcare's gender leadership gap.

Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman

Dr. Marty Makary summarizes four key takeaways following his Alliance of Community Health Plans keynote address on unnecessary care delivery.

Professor of Surgery and Health Policy, Johns Hopkins Medicine
Chief Medical Officer and Director, Clinical Innovation, Alliance of Community Health Plans

How a Chicago hub for healthcare innovation is evolving amidst an industry of fierce technological disruption.

CEO, MATTER

Insights from the Summit’s Executive Sessions where speakers dove deep into topics like consumerism, pharma, the future of trading flow, and artificial intelligence.

Insights in your inbox

Subscribe